FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke

Penumbra’s computer assisted vacuum thrombectomy platform uses aspiration for clot removal during acute ischemic stroke treatment. Penumbra’s computer assisted vacuum thrombectomy platform uses aspiration for clot removal during acute ischemic stroke treatment. Penumbra was acquired by Boston Scientific in a $14.5bn megadeal announced in January 2026. Credit: Anusorn Nakdee / Shutterstock.com Penumbra has secured US Food and Drug Administration (FDA) clearance for THUNDERBOLT, expanding the company’s computer-assisted vacuum thrombectomy (CAVT) lineup to address acute ischemic stroke. The latest product to market for the California-based company, which was acquired by Boston Scientific in a $14.5bn megadeal announced in January 2026, uses…

Source: Medical Device Network